AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
2.520
-0.040 (-1.56%)
May 6, 2024, 2:23 PM EDT - Market open
AN2 Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Hold
Price Target
$6.50
Upside
+157.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold → Buy Upgrades $6 | Hold → Buy | Upgrades | $6 | +138.10% | Apr 2, 2024 |
| Oppenheimer | Oppenheimer | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 1, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $23 → $7 | Buy → Hold | Downgrades | $23 → $7 | +177.78% | Feb 13, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $30 | Buy | Initiates | $30 | +1,090.48% | Jan 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $20 → $24 | Buy | Maintains | $20 → $24 | +852.38% | Mar 30, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $27 → $25 | Buy | Maintains | $27 → $25 | +892.06% | Nov 14, 2022 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $25 | Buy | Initiates | $25 | +892.06% | Apr 19, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $22 | Buy | Initiates | $22 | +773.02% | Apr 19, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 19, 2022 |